drugset / Trial / NCT06730308
Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma
NaSingle-groupOpen-labelTreatment
Summary
This study aims to assess the efficacy of methylprednisolone combined with concurrent chemoradiotherapy in treating unresectable or recurrent thymoma.
Timeline
- Start
- 2024-11-20
- Primary completion
- 2028-11-19
- Completion
- 2028-11-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 25 mg/m2 | — |
| Subject | Methylprednisolone | Other / unclassified | 2 mg/kg | — |
| Subject | Paclitaxel | Small molecule | 50 mg/m2 | — |